Evidence map›Paper›PMID 31767830›Full record

ArticleBlood cancer journal2019

Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia.

Marta Cuadros, Álvaro Andrades, Isabel F Coira, Carlos Baliñas, María I Rodríguez, Juan Carlos Álvarez-Pérez, Paola Peinado, Alberto M Arenas, Daniel J García, Pilar Jiménez and 3 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Targeting the lncRNA DUXAP8/miR-29a/Frontiers in oncology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Non-Coding RNA Signatures of B-Cell Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Marta CuadrosDepartment of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain.
Álvaro AndradesGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.ORCID http://orcid.org/0000-0001-9042-8964
Isabel F CoiraGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Carlos BaliñasGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
María I RodríguezGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Juan Carlos Álvarez-PérezGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Paola PeinadoGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Alberto M ArenasGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Daniel J GarcíaDepartment of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain.
Pilar JiménezHealth Research Institute of Granada (ibs.Granada), Granada, Spain.
Mireia CamósHematology Laboratory, Hospital Sant Joan de Déu Barcelona, University of Barcelona; Institut de Recerca Hospital Sant Joan de Deu Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Antonio Jiménez-VelascoHematology Laboratory, Universitary Regional Hospital, Málaga, Spain.
Pedro P MedinaGENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain. pedromedina@ugr.es.
Universidad de Granada · ESHospital Regional Universitario de Málaga · ESHospital Sant Joan de Déu Barcelona · ESHospital Universitario Virgen de las Nieves · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticRNA InterferenceBiomarkers, TumorCore Binding Factor Alpha 2 SubunitETS Translocation Variant 6 ProteinFemaleGene Expression ProfilingHumansMaleOncogene Proteins, FusionPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrognosisRNA, Long NoncodingBiomarkers, TumorCore Binding Factor Alpha 2 SubunitETS Translocation Variant 6 Proteinlong noncoding RNA TCL6, humanOncogene Proteins, FusionRNA, Long NoncodingTEL-AML1 fusion protein

Identifiers

PMID31767830
PMCPMC6877621
OpenAlexW2991583532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.